Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Guillermo Torre Insider Profile
4 Followers
Guillermo Torre, Director at Cardiol Therapeutics, holds 89.16K shares in Cardiol Therapeutics (Ticker: CRDL). Most recently, Guillermo Torre Bought $19,800 shares of Cardiol Therapeutics on Apr 05, 2022 for an estimated value of 28.48K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-74.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Guillermo Torre's holdings
Insider Roles
Director
Roles that Guillermo Torre holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 05, 2022 - Apr 05, 2023
Return:-74.50%
The most profitable trade made by Guillermo Torre
Guillermo Torre's Trading History
List of latest transactions for each holding click on a transaction to see Guillermo Torre's performance on stock
You May Also Like
Guillermo Torre insider profile FAQ
What is the percentage of profitable transactions made by Guillermo Torre?
The percentage of profitable transactions made by Guillermo Torre is 0%.
What is the average return per transaction made by Guillermo Torre?
The average return per transaction made by Guillermo Torre is -74.50%.
What stocks does Guillermo Torre hold?
Guillermo Torre holds: CRDL stocks.
What was Guillermo Torre’s latest transaction?
Guillermo Torre latest transaction was an Informative Buy of $28.48K.
What was Guillermo Torre's most profitable transaction?
Guillermo Torre’s most profitable transaction was an Informative Buy of CRDL stock on April 5, 2022. The return on the trade was -74.50%.
What is Guillermo Torre's role in Cardiol Therapeutics?
Guillermo Torre's role in Cardiol Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.